| Literature DB >> 28124881 |
Gulmira Umarova1, Saule Bermagambetova, Akmaral Baspakova, Umyt Satybaldieva, Valentina Sabyrakhmetova, Talgar Abilov, Gulnar Sultanova, Raisa Uraz.
Abstract
Objective: The dynamics of morbidity, disability and death rates due to malignant neoplasms in the population in Uralsk city of the Republic of Kazakhstan were studied for 2011-2015, with a focus on age and sex, as well as tumor location.Entities:
Keywords: Cancer rate; primary disablement; cancer mortality; city of Uralsk
Year: 2016 PMID: 28124881 PMCID: PMC5454652 DOI: 10.22034/APJCP.2016.17.12.5159
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Oncologic Diseases Rate among Men and Women for 2011-2015 (Per 100,000 of Population)
| Malignant neoplasms localization | Sex | Annual rate | ||||
|---|---|---|---|---|---|---|
| 2011 | 2012 | 2013 | 2014 | 2015 | ||
| All malignant neoplasms, including, | m | 213.3 | 213.4 | 219.1 | 249.2 | 235.6 |
| f | 226.6 | 241.9 | 229.9 | 249.5 | 244.4 | |
| lips | m | 1.4 | 2.1 | 2.4 | 2.8 | 1.0 |
| f | 0.0 | 1.4 | 1.0 | 1.0 | 1.0 | |
| tongue, oral cavity and larynx | m | 6.3 | 7.5 | 8.0 | 5.6 | 4.9 |
| f | 3.5 | 5.7 | 3.8 | 5.9 | 4.6 | |
| esophagus | m | 20.9 | 20.3 | 15.4 | 21.2 | 19.0 |
| f | 19.2 | 13.6 | 11.2 | 16.7 | 20.6 | |
| stomach | m | 22.3 | 24.6 | 23.7 | 32.7 | 27.5 |
| f | 11.2 | 14.3 | 12.2 | 16.0 | 8.5 | |
| segmented intestine | m | 6.3 | 13.2 | 12.2 | 11.5 | 11.4 |
| f | 12.5 | 14.3 | 10.1 | 13.6 | 10.5 | |
| straight intestine, rectosigmoid junction, anus | m | 9.1 | 8.2 | 11.5 | 9.0 | 14.4 |
| f | 7.0 | 8.6 | 11.5 | 10.8 | 8.5 | |
| hepar and intrahepatic bile ducts | m | 12.2 | 6.8 | 12.9 | 16.0 | 6.5 |
| f | 5.6 | 6.1 | 6.3 | 8.0 | 7.8 | |
| pancreatic gland | m | 5.9 | 7.5 | 8.0 | 9.7 | 6.5 |
| f | 5.6 | 7.8 | 9.4 | 8.7 | 7.2 | |
| larynx | m | 5.2 | 3.6 | 5.9 | 5.9 | 5.6 |
| f | 0.3 | 0.7 | 0.0 | 0.3 | 0.7 | |
| trachea, bronchi, lung | m | 46.4 | 48.2 | 40.5 | 51.1 | 50.3 |
| f | 9.4 | 8.2 | 9.1 | 7.6 | 9.2 | |
| bones and arthrodial cartilages | m | 0.7 | 1.4 | 1.0 | 0.3 | 0.7 |
| f | 1.4 | 0.7 | 1.0 | 1.0 | 1.0 | |
| connective and other soft tissues | m | 2.8 | 1.4 | 0.7 | 1.7 | 1.6 |
| f | 0.7 | 1.1 | 1.0 | 2.4 | 1.6 | |
| cutaneous melanoma | m | 0.7 | 0.7 | 0.0 | 0.7 | 2.0 |
| f | 1.4 | 0.7 | 0.7 | 0.3 | 1.3 | |
| other skin neoplasms | m | 13.6 | 9.3 | 14.3 | 18.4 | 17.0 |
| f | 17.4 | 12.1 | 15.0 | 21.9 | 23.2 | |
| female mammary glands | f | 48.1 | 65.6 | 54.4 | 51.1 | 56.2 |
| cervix uteri | f | 25.4 | 20.3 | 25.1 | 23.6 | 22.9 |
| body of uterus | f | 11.5 | 13.6 | 14.0 | 11.5 | 17.0 |
| ovary | f | 13.2 | 15.7 | 12.6 | 17.7 | 13.7 |
| prostate gland | m | 19.2 | 12.1 | 20.6 | 22.2 | 22.2 |
| testis | m | 1.4 | 2.1 | 1.7 | 1.7 | 2.6 |
| renal system | m | 7.7 | 7.1 | 8.4 | 7.0 | 5.2 |
| f | 5.2 | 5.0 | 6.3 | 3.8 | 2.9 | |
| urinary bladder | m | 6.3 | 6.4 | 8.4 | 9.7 | 8.2 |
| f | 1.0 | 0.7 | 1.7 | 1.4 | 1.6 | |
| eye and its appendages | m | 0.3 | 0.0 | 0.3 | 0.0 | 0.3 |
| f | 0.7 | 0.4 | 0.0 | 1.0 | 0.0 | |
| cerebrum and central nervous system | m | 3.5 | 5.4 | 3.1 | 5.2 | 5.6 |
| f | 1.4 | 3.9 | 2.1 | 2.8 | 2.9 | |
| thyroid | m | 0.7 | 0.7 | 1.4 | 0.0 | 0.3 |
| f | 2.8 | 0.7 | 4.9 | 4.5 | 4.9 | |
| lymphoid and blood-forming tissues | m | 11.2 | 10.3 | 10.1 | 9.0 | 10.8 |
| f | 10.8 | 11.1 | 7.3 | 7.0 | 6.9 | |
| other malignant neoplasms | m | 9.4 | 14.3 | 8.4 | 7.6 | 12.1 |
| f | 11.2 | 9.6 | 9.1 | 10.8 | 9.8 |
Figure 1Morbidity Rate of the Main Forms of Oncologic Neoplasms among Men (Per 100,000 of Population)
Figure 2Morbidity Rate of the Main Forms of Oncologic Neoplasms among Women (Per 100,000 of Population)
Figure 3Diseases Distribution Due to Malignant Neoplasms by Age of Patients for 2011-2015
Figure 3aDiseases Distribution Due to Malignant Neoplasms among Men for 2011-2015
Figure 3aDiseases Distribution Due to Malignant Neoplasms among Men for 2011-2015
Death Rate Due to Malignant Neoplasms (Per 100,000 of Population)
| Tumor localization | Sex | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|---|
| Malignant neoplasms, total | m | 130.4 | 138.8 | 113.4 | 116.1 | 110.1 |
| f | 96.2 | 98.5 | 104.7 | 97.7 | 91.5 | |
| including children up to 14 years old included | m | 1.4 | 1.1 | 1.0 | 1.0 | 2.3 |
| f | 0.7 | 0.7 | 0.3 | 0.7 | 1.3 | |
| From total amount – malignant neoplasms: lips | m | 0.3 | 0.4 | 0.7 | 0.0 | 0.3 |
| f | 0.0 | 0.4 | 0.3 | 0.0 | 0.0 | |
| tongue, oral cavity and larynx | m | 5.2 | 4.6 | 4.2 | 4.5 | 3.9 |
| f | 2.8 | 3.2 | 3.1 | 3.5 | 2.6 | |
| esophagus | m | 15.3 | 18.2 | 11.9 | 12.5 | 12.4 |
| f | 7.0 | 10.3 | 6.3 | 7.0 | 6.5 | |
| stomach | m | 16.4 | 14.6 | 15.4 | 13.6 | 14.1 |
| f | 7.0 | 10.7 | 10.5 | 10.8 | 9.5 | |
| segmented intestine | m | 5.6 | 5.7 | 6.3 | 4.2 | 6.5 |
| f | 5.2 | 5.0 | 5.9 | 4.2 | 5.2 | |
| straight intestine, rectosigmoid junction, anus | m | 4.5 | 4.3 | 4.9 | 7.0 | 4.2 |
| f | 3.5 | 3.6 | 4.2 | 3.8 | 3.6 | |
| hepar | m | 7.0 | 3.9 | 5.9 | 8.3 | 5.2 |
| f | 5.2 | 3.6 | 3.5 | 7.0 | 4.9 | |
| pancreatic gland | m | 4.5 | 6.1 | 6.6 | 4.9 | 5.9 |
| f | 3.5 | 5.7 | 3.5 | 5.6 | 5.9 | |
| larynx | m | 3.5 | 1.4 | 2.8 | 2.8 | 2.3 |
| f | 1.7 | 1.1 | 1.4 | 1.7 | 1.0 | |
| trachea, bronchi, lung | m | 30.0 | 25.3 | 24.8 | 22.9 | 22.2 |
| f | 15.0 | 17.8 | 24.8 | 10.4 | 9.8 | |
| bones and arthrodial cartilages | m | 1.0 | 1.1 | 0.7 | 0.3 | 1.3 |
| f | 0.7 | 1.1 | 0.3 | 0.3 | 0.7 | |
| connective and other soft tissues | m | 1.0 | 0.4 | 1.7 | 1.0 | 0.7 |
| f | 1.7 | 0.4 | 1.4 | 0.3 | 1.3 | |
| cutaneous melanoma | m | 0.7 | 0.4 | 0.0 | 0.0 | 0.7 |
| f | 0.7 | 0.0 | 0.0 | 0.7 | 0.3 | |
| other skin neoplasms*) | m | 0.0 | 0.4 | 0.0 | 0.3 | 0.0 |
| f | 0.3 | 0.0 | 0.0 | 0.3 | 0.3 | |
| female mammary glands | f | 15.3 | 17.5 | 15.7 | 16.0 | 15.4 |
| cervix uteri | f | 9.1 | 10.0 | 6.6 | 11.1 | 6.5 |
| body of uterus | f | 4.2 | 3.2 | 3.1 | 3.5 | 0.7 |
| ovary | f | 4.9 | 6.1 | 5.9 | 8.7 | 9.2 |
| prostate gland | m | 3.1 | 7.8 | 3.8 | 4.2 | 3.6 |
| testis | m | 0.7 | 0.4 | 0.3 | 0.3 | 0.3 |
| renal system | m | 4.2 | 2.1 | 2.4 | 2.1 | 1.3 |
| f | 3.5 | 2.1 | 1.7 | 3.5 | 1.6 | |
| urinary bladder | m | 2.4 | 1.4 | 2.4 | 2.4 | 1.3 |
| f | 2.1 | 0.7 | 2.4 | 1.7 | 2.0 | |
| eye and its appendages | m | 0.3 | 0.0 | 0.0 | 0.3 | 0.0 |
| f | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| cerebrum and CNS | m | 2.8 | 2.9 | 2.4 | 1.4 | 1.6 |
| f | 2.1 | 2.1 | 1.7 | 1.4 | 2.3 | |
| thyroid | m | 0.3 | 0.7 | 1.0 | 0.3 | 0.3 |
| f | 0.0 | 0.4 | 0.3 | 0.7 | 0.3 | |
| malignant lymphadenosis | m | 2.4 | 2.1 | 1.7 | 2.4 | 2.9 |
| f | 1.7 | 2.9 | 1.7 | 2.4 | 3.3 | |
| leukaemia | m | 4.5 | 5.4 | 3.5 | 3.5 | 3.3 |
| f | 3.5 | 3.6 | 3.5 | 3.1 | 1.6 | |
| others | m | 6.6 | 9.3 | 7.0 | 6.3 | 9.5 |
| f | 3.5 | 7.1 | 6.3 | 3.5 | 3.3 |